Michael S. Kinch, PhD

Associate Vice Chancellor and Director, Center for Research Innovation in Business, and Professor of Radiation Oncology, School of Medicine
drug development & delivery, emerging technology, government

Dr. Kinch examines the practices and organizations involved in research and development of new therapeutic agents and devices. Specifically, he has evaluated people and organizations involved in the preclinical and clinical activities necessary for the approval of an FDA-approved drugs or devices. His work has further evaluated how these activities have changed over time, as well as the fate of the organizations and individuals that have contributed to an FDA-approved product.

Article in the Washington University Record about Dr. Kinch's appointment.